Birmingham, West Midlands -- (SBWIRE) -- 02/20/2013 -- Value Penny Stock key goal and commitment to our members is to provide you with exclusive newsletter that represents our reliability, and differentiates us from the other promotional newsletters! We pride ourselves in presenting picks that will make our followers money on a regular basis, as well as staying away from the stocks that are frequently being diluted.
Gilead Sciences, Inc. (NASDAQ:GILD)has declared a voluntary recall of one of its products, Vistide® (cidofovir injection), lot # B120217A, due to the occurrence of particulate problem found in some vials of this proportion.Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need.
In the last trading session, Gilead Sciences, Inc. (NASDAQ:GILD) gained +1.63% and closed at $42.28 with the overall traded volume of 11.54 million shares more than the average volume of 9.43 million.
What was the Moving Force behind GILD on Bullish Run? Read This Research Report on GILD
Dendreon Corporation (NASDAQ:DNDN) jumped +0.58% with the closing price of $6.10. The overall volume in the last trading session was 8.62 million shares. Its fifty two week range was $3.69-$15.20. The total market capitalization remained $941.33million.
DNDN is ahead its 52 week low with 65.31% and its last month price volatility remained 5.99%. Its beta coefficient was 3.89 with a target price of $6.24. DNDN has insider ownership of 2.86% with its institutional ownership remained 62.39%. Company’s current year earnings per share grew with 27.32% while the five year EPS growth rate was +12.65%.
For How Long DNDN will fight for Profitability? Read This Trend Analysis report
Galena Biopharma Inc (NASDAQ:GALE) reported the gain of +9.32% and closed at $2.00 in the last trading session with the total traded volume of 6.21 million shares. Stock price 52 weeks high was $3.54 and 52 weeks low price was $0.94. Galena Biopharma, Inc. (Galena), formerly RXi Pharmaceuticals Corporation, is a biotechnology company focused on discovering, developing and commercializing therapies addressing unmet medical needs using targeted biotherapeutics.
For How Long GALE’s Gloss will Attract Investors? Find out via this report
Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) surged +5.10% and closed at $21.02in the last trading session with the total traded volume of 4.72 million shares. ARIA has outstanding shares of 166.66 million with the total market cap of 3.50 billion. ARIAD Pharmaceuticals, Inc. (ARIAD) is a global oncology company focused on the discovery, development and commercialization of medicines for the cancer patients.
Will ARIA Continue To Move Higher? Find Out Here
About Value Penny Stocks
Value Penny Stocks was made by Two Active traders Steve and Wilson whom have make a platform for trader in order to provide traders #1 Penny Stock Newsletter which actually give your value to your money and make your portfolio full of Profits. We concentrate on value small cap stocks that trade on NYSE, NASD, AMEX, OTCBB, and OTC exchanges. These are usually stocks that will trade under $5 a share and offer the utmost potential profit on your short or long term investment. We also devotes ourselves in understanding the overall market situations, and use this knowledge in order to gain a better perception during our stock picking decisions.
We at valueValuePennyStocks.com are engaged in the business of marketing and advertising companies. All content on our website is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities.
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-321-1250 (International)